Skip to content
Baltimore News Journal – Lifestyle
Author:
Sebela Pharmaceuticals
Sebela Pharmaceuticals to Present Positive Phase 3 Tegoprazan Data in Non-Erosive Reflux Disease (NERD) at the American College of Gastroenterology (ACG) 2026 Meeting
October 11, 2026